相似文献
1
Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
Urology. 1975 Jul;6(1):17-21. doi: 10.1016/0090-4295(75)90585-3.
2
Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Prog Clin Biol Res. 1989;303:177-86.
3
Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
J Urol. 1977 Dec;118(6):1013-8. doi: 10.1016/s0022-5347(17)58281-6.
4
Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
Urology. 1984 Jun;23(6 Suppl):64-8. doi: 10.1016/s0090-4295(84)80101-6.
5
[Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Hinyokika Kiyo. 1986 Nov;32(11):1763-70.
6
French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Prog Clin Biol Res. 1987;243B:229-34.
7
A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
J Urol. 1986 Sep;136(3):619-23. doi: 10.1016/s0022-5347(17)44995-0.
8
9
Estramustine for prostate cancer.
Med Lett Drugs Ther. 1982 Aug 6;24(615):74.
10
Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
Br J Urol. 1983 Aug;55(4):408-12. doi: 10.1111/j.1464-410x.1983.tb03333.x.
Zotero 插件